It is not approved by the TGA for human or veterinary use and is not sold as a medicine or supplement
The Dual Agonist Advantage: GLP-1 and GIP Unlike earlier medications that targeted only one pathway, tirzepatide is a novel dual agonist, mimicking the action of two naturally occurring incretin hormones: glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP)
Weight regain is a possibility with both medications when treatment ends, which is why obesity is increasingly treated as a chronic condition that benefits from long-term, supervised care
But when youre looking at branded items, the ingredients and nutrition profiles can vary more than youd expect
Klinic's experienced team is here to provide clarity and ensure a seamless start to your weight loss journey
No significant differences were seen for the primary outcome measure of changes in intestinal permeability as determined by urinary lactulose to mannitol ratio